{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:38:48Z","timestamp":1791826728500,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ebiom.2021.103249","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T23:25:42Z","timestamp":1614209142000},"page":"103249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation"],"prefix":"10.1016","volume":"65","author":[{"given":"Nadia","family":"Panera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Crudele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Bellacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"D'Oria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Ludovica","family":"Fracanzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Alisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4343-7213","authenticated-orcid":false,"given":"Paola","family":"Dongiovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2021.103249_bib0001","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2021.103249_bib0002","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2021.103249_bib0003","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2021.103249_bib0004","article-title":"Nutrition and genetics in NAFLD","volume":"21","author":"Meroni","year":"2020","journal-title":"The Perfect Binomium"},{"key":"10.1016\/j.ebiom.2021.103249_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2021.103249_bib0006","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2021.103249_bib0007","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23823","article-title":"I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease","volume":"52","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2021.103249_bib0008","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.3748\/wjg.v20.i36.12945","article-title":"Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors","volume":"20","author":"Dongiovanni","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ebiom.2021.103249_bib0009","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.27490","article-title":"Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease","volume":"61","author":"Dongiovanni","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2021.103249_bib0010","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2021.103249_bib0011","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jhep.2019.10.011","article-title":"\u03b2-Klotho gene variation is associated with liver damage in children with NAFLD","volume":"72","author":"Dongiovanni","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2021.103249_bib0012","doi-asserted-by":"crossref","first-page":"E833","DOI":"10.1152\/ajpendo.00182.2018","article-title":"\u03b2-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice","volume":"315","author":"Somm","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ebiom.2021.103249_bib0013","unstructured":"Schumann G., Liu C., O'Reilly P., et\u00a0al. KLB is associated with alcohol drinking, and its gene product \u03b2-Klotho is necessary for FGF21 regulation of alcohol preference. 2016;113:14372\u20137."},{"key":"10.1016\/j.ebiom.2021.103249_bib0014","first-page":"315","article-title":"Evaluation of the effect of oral taurine supplementation on fasting levels of fibroblast growth factors, \u03b2-Klotho co-receptor, some biochemical indices and body composition in obese women on a weight-loss diet: a study protocol for a double-blind","volume":"20","author":"Haidari","year":"2019","journal-title":"Random Control Trial"},{"key":"10.1016\/j.ebiom.2021.103249_bib0015","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1210\/me.2015-1155","article-title":"Minireview: roles of Fibroblast growth factors 19 and 21 in metabolic regulation and chronic diseases","volume":"29","author":"Zhang","year":"2015","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ebiom.2021.103249_bib0016","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.molmet.2017.03.009","article-title":"FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue","volume":"6","author":"Markan","year":"2017","journal-title":"Mol Metab"},{"key":"10.1016\/j.ebiom.2021.103249_bib0017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2021.103249_bib0018","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1172\/JCI26046","article-title":"Weaving betaKlotho into bile acid metabolism","volume":"115","author":"Moschetta","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2021.103249_bib0019","doi-asserted-by":"crossref","unstructured":"Puri P., Daita K., Joyce A., et\u00a0al. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. 2018;67:534\u201348.","DOI":"10.1002\/hep.29359"},{"key":"10.1016\/j.ebiom.2021.103249_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPG.0000000000000774","article-title":"Serum bile acid levels in children with nonalcoholic fatty liver disease","volume":"61","author":"Jahnel","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ebiom.2021.103249_bib0021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tem.2014.10.002","article-title":"Tissue-specific actions of the metabolic hormones FGF15\/19 and FGF21","volume":"26","author":"Owen","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ebiom.2021.103249_bib0022","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2021.103249_bib0023","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.clnu.2016.04.027","article-title":"FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss","volume":"36","author":"G\u00f3mez-Ambrosi","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ebiom.2021.103249_bib0024","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ijo.2014.76","article-title":"Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients","volume":"39","author":"Gallego-Escuredo","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ebiom.2021.103249_bib0025","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2021.103249_bib0026","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/j.gastro.2016.03.009","article-title":"Comparison of the phenotype and approach to pediatric vs adult patients with nonalcoholic fatty liver disease","volume":"150","author":"Nobili","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2021.103249_bib0027","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2021.103249_bib0028","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2015.05.006","article-title":"Statin use and non-alcoholic steatohepatitis in at risk individuals","volume":"63","author":"Dongiovanni","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2021.103249_bib0029","doi-asserted-by":"crossref","unstructured":"Dongiovanni P., Meroni M., Baselli G., et\u00a0al. PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients. 2019;60:1144\u201353.","DOI":"10.1194\/jlr.P090449"},{"key":"10.1016\/j.ebiom.2021.103249_bib0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2021.103249_bib0031","doi-asserted-by":"crossref","unstructured":"Lo Re O., Panebianco C., Porto S., et\u00a0al. Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells. 2018;233:1202\u201312.","DOI":"10.1002\/jcp.25987"},{"key":"10.1016\/j.ebiom.2021.103249_bib0032","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2021.103249_bib0033","doi-asserted-by":"crossref","first-page":"W350","DOI":"10.1093\/nar\/gky300","article-title":"DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability","volume":"46","author":"Rodrigues","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2021.103249_bib0034","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.phrs.2018.02.033","article-title":"Disruption of TFG\u03b2-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand","volume":"131","author":"Carino","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ebiom.2021.103249_bib0035","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2021.103249_bib0036","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.18632\/aging.102293","article-title":"KLB gene polymorphism is associated with obesity and non-alcoholic fatty liver disease in the Han Chinese","volume":"11","author":"Ji","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ebiom.2021.103249_bib0037","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijms.2017.05.010","article-title":"Mass spectrometric analysis of the N-glycoproteome in statin-treated liver cells with two lectin-independent chemical enrichment methods","volume":"429","author":"Xiao","year":"2018","journal-title":"Int J Mass Spectrom"},{"key":"10.1016\/j.ebiom.2021.103249_bib0038","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.1038\/srep08926","article-title":"Effects of N-glycosylation on protein conformation and dynamics: protein data bank analysis and molecular dynamics simulation study","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:02:14Z","timestamp":1762455734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":38,"alternative-id":["S2352396421000426"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103249","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103249"}}